Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Hormone replacement therapy and increased plasma concentration of C-reactive protein.

Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE.

Circulation. 1999 Aug 17;100(7):713-6.

2.

Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.

Barinas-Mitchell E, Cushman M, Meilahn EN, Tracy RP, Kuller LH.

Am J Epidemiol. 2001 Jun 1;153(11):1094-101.

PMID:
11390329
3.

Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.

Yilmazer M, Fenkci V, Fenkci S, Sonmezer M, Aktepe O, Altindis M, Kurtay G.

Maturitas. 2003 Dec 10;46(4):245-53.

PMID:
14625121
4.

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.

Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM.

Circulation. 2003 Jul 1;107(25):3165-9. Epub 2003 Jun 9.

5.

Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?

Bukowska H, Stanosz S, Zochowska E, Millo B, Sieja K, CheĊ‚stowski K, Naruszewicz M.

Metabolism. 2005 Jan;54(1):72-8.

PMID:
15562383
6.

Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.

Vitale C, Gebara O, Mercuro G, Wajngarten M, Silvestri A, Rossini P, Ramires JA, Fini M, Rosano GM.

Maturitas. 2005 Apr 11;50(4):239-46.

PMID:
15780522
7.

Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.

de Maat MP, Madsen JS, Langdahl B, Bladbjerg EM, Tofteng CL, Abrahamsen B, Rejnmark L, Brixen K, Christensen K, Jespersen J, Kristensen SR.

Thromb Haemost. 2007 Feb;97(2):234-9.

PMID:
17264952
8.

Influence of hormone replacement therapy on C-reactive protein: population-based data.

Primatesta P, Falaschetti E, Poulter NR.

J Cardiovasc Risk. 2003 Feb;10(1):57-60.

PMID:
12569237
9.

Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.

Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM.

Ann Epidemiol. 2006 Feb;16(2):105-12. Epub 2005 Oct 10.

PMID:
16216530
10.

Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.

Manns PJ, Williams DP, Snow CM, Wander RC.

Am J Hum Biol. 2003 Jan-Feb;15(1):91-100.

PMID:
12552583
11.

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

Oger E, Alhenc-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, Pujol Y, Scarabin P.

Thromb Res. 2001 Jan 15;101(2):35-43.

PMID:
11342204
12.

Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.

Albert MA, Glynn RJ, Ridker PM.

Circulation. 2003 Jul 15;108(2):161-5. Epub 2003 Jun 30.

13.

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.

Streja D, Cressey P, Rabkin SW.

J Diabetes Complications. 2003 May-Jun;17(3):120-7.

PMID:
12738395
14.

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1668-73.

15.

Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.

Ryan AS, Nicklas BJ, Berman DM.

Diabetes Care. 2002 Jan;25(1):127-33.

PMID:
11772913
17.

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

Cushman M, Legault C, Barrett-Connor E, Stefanick ML, Kessler C, Judd HL, Sakkinen PA, Tracy RP.

Circulation. 1999 Aug 17;100(7):717-22.

18.

C-reactive protein is independently associated with fasting insulin in nondiabetic women.

Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM.

Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):650-5. Epub 2003 Mar 6.

19.

Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial.

Crandall C, Palla S, Reboussin B, Hu P, Barrett-Connor E, Reuben D, Greendale G.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):14-23.

PMID:
16417414
20.

Alcohol consumption and plasma concentration of C-reactive protein.

Albert MA, Glynn RJ, Ridker PM.

Circulation. 2003 Jan 28;107(3):443-7.

Supplemental Content

Support Center